| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |